发明名称 USE OF HEPCIDIN FOR PREPARING PHARMACEUTICAL AGENT FOR TREATING DISORDER OF IRON HOMEOSTASIS
摘要 <P>PROBLEM TO BE SOLVED: To provide a pharmaceutical agent for treating disorders of iron homeostasis. <P>SOLUTION: A complete defect in hepcidin expression shows the induction of progressive tissue iron overload in mice. Also, transgenic mice expressing hepcidin under regulation of a compositional liver-specific promotor are anaemic. Therefore, antisense RNA or DNA, or lipozyme likely inhibiting activity or expression of hepcidin can be used for treating anaemia associated with chronic diseases. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009143938(A) 申请公布日期 2009.07.02
申请号 JP20090006614 申请日期 2009.01.15
申请人 INST NATIONAL DE LA SANTE & DE LA RECHERCHE MEDICAL (INSERM) 发明人 NICOLAS GAEL;VAULONT SOPHIE;KAHN AXEL
分类号 A01K67/027;A61K31/7105;A61K31/711;A61K38/00;A61K38/03;A61K38/17;A61K45/00;A61K48/00;A61P3/10;A61P3/12;A61P7/06;A61P9/10;A61P35/00;A61P43/00;C07K7/04;C12N15/09;C12Q1/68;G01N33/15;G01N33/50;G01N33/68;G01N33/90 主分类号 A01K67/027
代理机构 代理人
主权项
地址